F18 RADIOPHARMACEUTICALS

The Department of Veterans Affairs has issued this sources sought notice, solicitation number 36C24726Q0232, to identify established commercial radiopharmacies capable of providing and delivering various F18 radiopharmaceuticals. The required products include F-18 FDG, NaF-F18, F18-beta-amyloid imaging agents, F18-Axumin, F18-Tauvid, F18-Cerianna, F18-Posluma, F18-Pylarify, choline PET radiopharmaceuticals, and F18-FET. The contractor must provide all labor, supervision, and transportation necessary for daily deliveries to the Nuclear Medicine Service at the Atlanta Veterans Affairs Medical Center in Decatur, Georgia.

Eligible vendors must have operated continuously for at least 10 years and maintain a needleless system for ordering, shipping, and returning spent syringes in compliance with OSHA Biohazardous Waste Policy. Requirements include licensing by the U.S. NRC or an Agreement State and documentation of FDA approval for the cyclotrons used in production. The scope of work involves a comprehensive return policy for full credit regarding products shipped in error, damaged items, recalled materials, or expired products in unopened original containers.

This requirement is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC Q527, Medical-Nuclear Medicine. There is no set-aside designated for this notice. Responses are due by January 26, 2026, and the primary point of contact is Natasha Mixon. Supporting documentation is available via one attachment titled RFI-36C24726Q0232-F18 Radiopharmaceuticals.pdf.